Compare Fulford India with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs JUBILANT LIFE SCIENCES - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA JUBILANT LIFE SCIENCES FULFORD INDIA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 398.8 13.9 2,875.4% View Chart
P/BV x 6.2 1.6 383.8% View Chart
Dividend Yield % 0.1 0.9 9.2%  

Financials

 FULFORD INDIA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
JUBILANT LIFE SCIENCES
Mar-19
FULFORD INDIA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs942898 104.9%   
Low Rs450618 72.9%   
Sales per share (Unadj.) Rs691.4572.0 120.9%  
Earnings per share (Unadj.) Rs11.536.2 31.6%  
Cash flow per share (Unadj.) Rs15.459.5 25.8%  
Dividends per share (Unadj.) Rs2.004.50 44.4%  
Dividend yield (eoy) %0.30.6 48.4%  
Book value per share (Unadj.) Rs380.0301.9 125.9%  
Shares outstanding (eoy) m3.90159.28 2.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.3 76.0%   
Avg P/E ratio x60.720.9 290.3%  
P/CF ratio (eoy) x45.312.7 355.9%  
Price / Book Value ratio x1.82.5 73.0%  
Dividend payout %17.412.4 140.5%   
Avg Mkt Cap Rs m2,714120,694 2.2%   
No. of employees `0000.42.4 18.6%   
Total wages/salary Rs m50519,260 2.6%   
Avg. sales/employee Rs Th6,073.038,120.6 15.9%   
Avg. wages/employee Rs Th1,137.48,058.4 14.1%   
Avg. net profit/employee Rs Th100.72,414.3 4.2%   
INCOME DATA
Net Sales Rs m2,69691,108 3.0%  
Other income Rs m125357 35.1%   
Total revenues Rs m2,82291,466 3.1%   
Gross profit Rs m-4617,390 -0.3%  
Depreciation Rs m153,709 0.4%   
Interest Rs m102,198 0.4%   
Profit before tax Rs m5411,840 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m103,268 0.3%   
Profit after tax Rs m455,770 0.8%  
Gross profit margin %-1.719.1 -9.0%  
Effective tax rate %17.727.6 64.1%   
Net profit margin %1.76.3 26.2%  
BALANCE SHEET DATA
Current assets Rs m1,73845,848 3.8%   
Current liabilities Rs m54520,897 2.6%   
Net working cap to sales %44.327.4 161.6%  
Current ratio x3.22.2 145.5%  
Inventory Days Days4857 85.3%  
Debtors Days Days451 8.5%  
Net fixed assets Rs m1265,498 0.0%   
Share capital Rs m39159 24.5%   
"Free" reserves Rs m1,44347,930 3.0%   
Net worth Rs m1,48248,089 3.1%   
Long term debt Rs m042,429 0.0%   
Total assets Rs m2,077114,685 1.8%  
Interest coverage x6.76.4 105.2%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x1.30.8 163.4%   
Return on assets %2.66.9 37.6%  
Return on equity %3.012.0 25.1%  
Return on capital %4.312.4 34.7%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m1712,422 0.1%   
Fx outflow Rs m67317,227 3.9%   
Net fx Rs m-656-4,805 13.7%   
CASH FLOW
From Operations Rs m9011,215 0.8%  
From Investments Rs m105-10,118 -1.0%  
From Financial Activity Rs m-146,574 -0.2%  
Net Cashflow Rs m1817,612 2.4%  

Share Holding

Indian Promoters % 0.0 45.6 -  
Foreign collaborators % 75.0 3.5 2,142.9%  
Indian inst/Mut Fund % 3.8 8.7 43.7%  
FIIs % 0.1 21.2 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 21.1 100.5%  
Shareholders   4,783 23,815 20.1%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  GLENMARK PHARMA  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Gains; Tata Motors & ONGC Climb 5%(12:30 pm)

Share markets in India have extended early morning gains and are presently trading higher. Investors are cautious ahead of the release of Consumer Price Index-based inflation.

Related Views on News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - NOVARTIS COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS